Abstract
Substrates for glucuronidation include endogenous and xenobiotic compounds such as environmental carcinogens and drugs, as well as the chemotherapeutic agent irinotecan. The UDP-glucuronosyltransferase (UGT) 1A7 gene is expressed in the upper gastrointestinal tract and the lung but is not expressed in the liver. The transcriptional regulation of UGT1A7 and the putative influence of single nucleotide polymorphisms (SNPs) are incompletely characterized. UGT1A8, UGT1A9, and UGT1A10, which are highly homologous to UGT1A7, have been reported to be transcriptionally regulated by hepatocyte nuclear factors (HNFs). In this study, we show the activation of UGT1A7 by the aforementioned transcription factors. Sequence analyses, mutagenesis, reporter gene experiments, small interfering RNA silencing, chromatin immunoprecipitation, and electromobility shift assays identified five HNF binding sites in the proximal promoter region of UGT1A7 that were regulated by HNF1α and HNF4α. Activation by HNF1α was lower in the presence of the UGT1A7 −57G SNP. In contrast to liver-expressed UGT1A9, transcriptional activation of UGT1A7 by HNF4α was lower and dependent on higher HNF4α concentrations, which may contribute to the observed differences in tissue expression patterns. Therefore, a specific role of HNF in the transcriptional control of UGT1A7 is shown and characterized, which may contribute to its tissue specificity and function.
Footnotes
This work was supported in part by Deutsche Forschungsgemeinschaft [Grant SFB621-C3] (to C.P.S.).
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
doi:10.1124/dmd.109.030403.
-
ABBREVIATIONS:
- UGT
- UDP glucuronosyltransferase
- HNF
- hepatocyte nuclear factor
- SNP
- single nucleotide polymorphism
- HEK
- human embryonic kidney
- siRNA
- small interfering RNA
- bp
- base pair
- EMSA
- electrophoretic mobility shift assay
- ChIP
- chromatin immunoprecipitation.
- Received September 24, 2009.
- Accepted April 20, 2010.
- Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|